Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
People Who Made a Difference: Ed Morgan, President, The Emerson Group
“My job is about supporting our leaders,” Morgan says. “Ensuring they have what they need to deliver the best possible outcomes for the brands we represent.”
Hy-Vee expands private brand portfolio with ‘Nothing But The Truth’
Dietitian-developed line targets growing demand for better-for-you foods with clean labels and accessible pricing.
April Showers to launch ‘Magic Makers’ entrepreneur talk show on AfroLandTV
The new series, which debuted on January 19, spotlights founders behind consumer brands that have scaled into national retail distribution.
Southeastern Grocers rebrands as The Winn-Dixie Company
“This is a defining moment, more than a name change. It proudly declares who we are and where we’re headed,” said Anthony Hucker, chairman and CEO of The Winn-Dixie Company.